BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 30934989)

  • 1. A UHPLC-UV Method Development and Validation for Determining Kavalactones and Flavokavains in
    Tang Y; Fields C
    Molecules; 2019 Mar; 24(7):. PubMed ID: 30934989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single-Lab Validation for Determination of Kavalactones and Flavokavains in Piper methysticum (Kava).
    Liu Y; Lund JA; Murch SJ; Brown PN
    Planta Med; 2018 Nov; 84(16):1213-1218. PubMed ID: 29940660
    [No Abstract]   [Full Text] [Related]  

  • 3. Characterization of Different Forms of Kava (Piper methysticum) Products by UPLC-MS/MS.
    Mamallapalli J; Kanumuri SRR; Corral P; Johnston E; Zhuang C; McCurdy CR; Mathews CA; Sharma A; Xing C
    Planta Med; 2022 Nov; 88(14):1348-1359. PubMed ID: 34839465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical pharmacokinetics of kavalactones after oral dosing of standardized kava extract in healthy volunteers.
    Kanumuri SRR; Mamallapalli J; Nelson R; McCurdy CR; Mathews CA; Xing C; Sharma A
    J Ethnopharmacol; 2022 Oct; 297():115514. PubMed ID: 35777607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative Determination of Lactones in Piper methysticum (Kava-Kava) by Supercritical Fluid Chromatography.
    Murauer A; Ganzera M
    Planta Med; 2017 Aug; 83(12-13):1053-1057. PubMed ID: 28095587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of six kavalactones in dietary supplements and selected functional foods containing Piper methysticum by isocratic liquid chromatography with internal standard.
    Hu L; Jhoo JW; Ang CY; Dinovi M; Mattia A
    J AOAC Int; 2005; 88(1):16-25. PubMed ID: 15759721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electrospray high performance liquid chromatography-mass spectrometry in phytochemical analysis of kava (Piper methysticum) extract.
    He XG; Lin LZ; Lian LZ
    Planta Med; 1997 Feb; 63(1):70-4. PubMed ID: 17252331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simultaneous quantitation of kavalactones in kava dry extracts: comparison of multi-standards and single standard validation approaches.
    Ferreira JV; Pierotte IC; Pianetti GA; César IC
    Phytochem Anal; 2021 Sep; 32(5):740-748. PubMed ID: 33615586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemical and in vitro toxicity analysis of a supercritical fluid extract of Kava kava (Piper methysticum).
    Petersen GE; Tang Y; Fields C
    J Ethnopharmacol; 2019 May; 235():301-308. PubMed ID: 30710733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methysticin and 7,8-dihydromethysticin are two major kavalactones in kava extract to induce CYP1A1.
    Li Y; Mei H; Wu Q; Zhang S; Fang JL; Shi L; Guo L
    Toxicol Sci; 2011 Dec; 124(2):388-99. PubMed ID: 21908763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro inhibition of carboxylesterase 1 by Kava (Piper methysticum) Kavalactones.
    Melchert PW; Qian Y; Zhang Q; Klee BO; Xing C; Markowitz JS
    Chem Biol Interact; 2022 Apr; 357():109883. PubMed ID: 35278473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective effect of kava constituents in an in vitro model of oral mucositis.
    Yiannis C; Huang K; Tran AN; Zeng C; Dao E; Baselyous O; Mithwani MA; Paolini R; Cirillo N; Yap T; McCullough M; Celentano A
    J Cancer Res Clin Oncol; 2020 Jul; 146(7):1801-1811. PubMed ID: 32435894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolation and Purification of Potent Growth Inhibitors from
    Van TM; Xuan TD; Minh TN; Quan NV
    Molecules; 2018 Jul; 23(8):. PubMed ID: 30065174
    [No Abstract]   [Full Text] [Related]  

  • 14. Kavalactones from Kava (Piper methysticum) root extract as modulators of recombinant human glycine receptors.
    Hegazy NH; Breitinger HG; Breitinger U
    Biol Chem; 2019 Aug; 400(9):1205-1215. PubMed ID: 31141476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoamine Oxidase Inhibition by Kavalactones from Kava (Piper Methysticum).
    Prinsloo D; van Dyk S; Petzer A; Petzer JP
    Planta Med; 2019 Oct; 85(14-15):1136-1142. PubMed ID: 31539917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extracts and kavalactones of Piper methysticum G. Forst (kava-kava) inhibit P-glycoprotein in vitro.
    Weiss J; Sauer A; Frank A; Unger M
    Drug Metab Dispos; 2005 Nov; 33(11):1580-3. PubMed ID: 16051732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fourier transform ion cyclotron resonance mass spectrometry for the characterisation of kavalactones in the kava plant: elemental formulae confirmation by dual spray accurate mass measurement and structural confirmation by infrared multiphoton dissociation and sustained off-resonance irradiation collision induced dissociation.
    Warburton E; Bristow T
    Eur J Mass Spectrom (Chichester); 2006; 12(4):223-33. PubMed ID: 17057279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of various Piper methysticum cultivars with CNS receptors in vitro.
    Dinh LD; Simmen U; Bueter KB; Bueter B; Lundstrom K; Schaffner W
    Planta Med; 2001 Jun; 67(4):306-11. PubMed ID: 11458444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of cytochrome P450 3A4 by extracts and kavalactones of Piper methysticum (Kava-Kava).
    Unger M; Holzgrabe U; Jacobsen W; Cummins C; Benet LZ
    Planta Med; 2002 Dec; 68(12):1055-8. PubMed ID: 12494328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of kavalactones from Piper methysticum (kava-kava).
    Bilia AR; Scalise L; Bergonzi MC; Vincieri FF
    J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Dec; 812(1-2):203-14. PubMed ID: 15556499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.